CREDIT SUISSE AG 13D and 13G filings for UroGen Pharma Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 1:44 pm Sale | 2021-12-31 | 13G | UroGen Pharma Ltd. URGN | CREDIT SUISSE AG | 1,085,749 4.840% | -35,322 (-3.15%) | Filing |
| 2021-02-12 4:03 pm Purchase | 2020-12-31 | 13G | UroGen Pharma Ltd. URGN | CREDIT SUISSE AG | 1,121,071 5.070% | 1,121,071 (New Position) | Filing |